AlphaCrest Capital Management’s Teladoc Health TDOC Stock Holding History

AlphaCrest Capital Management’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-101,758	Closed	-$2.58M	–	1021
2022 Q3	$2.58M	Buy	101,758 +51,209	+101%	+$1.8M	0.16%	142
2022 Q2	$1.68M	Buy	50,549 +33,182	+191%	+$1.41M	0.08%	419
2022 Q1	$1.25M	Sell	17,367 -15,572	-47%	-$1.12M	0.07%	441
2021 Q4	$3.02M	Buy	32,939 +14,127	+75%	+$1.69M	0.11%	223
2021 Q3	$2.39M	Buy	18,812 +872	+5%	+$127K	0.12%	217
2021 Q2	$2.98M	Buy	17,940 +851	+5%	+$138K	0.13%	214
2021 Q1	$3.11M	Buy	17,089 +8,357	+96%	+$1.94M	0.17%	140
2020 Q4	$1.75M	Buy	8,732 +6,009	+221%	+$1.22M	0.15%	172
2020 Q3	$597K	Buy	+2,723	New	+$577K	0.06%	488
2020 Q1	–	Sell	-4,300	Closed	-$360K	–	1268
2019 Q4	$360K	Sell	4,300 -2,300	-35%	-$175K	0.03%	966
2019 Q3	$447K	Buy	+6,600	New	+$434K	0.03%	965

Other funds holding TDOC

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SOMRS

State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return

Kinnevik AB Stockholm, Sweden $65.6M AUM 25.95% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

AlphaCrest Capital Management's TDOC Position: Q4 2022 in Review

AlphaCrest Capital Management sold out of Teladoc Health (TDOC) in Q4 2022, closing a stake of 101,758 shares — an estimated $2.58M sold.

AlphaCrest Capital Management first reported a position in TDOC in Q3 2019 and held it in 11 quarters. The position peaked at $3.11M in Q1 2021. 445 funds tracked by Wall St. Rank hold TDOC as of Q4 2022.

AlphaCrest Capital Management reported no remaining Teladoc Health position as of Q4 2022 after selling out during the quarter.
AlphaCrest Capital Management sold 101,758 Teladoc Health shares in Q4 2022, an estimated $2.58M.
AlphaCrest Capital Management first reported a position in Teladoc Health in Q3 2019 and held it in 11 quarters.
AlphaCrest Capital Management's Teladoc Health position peaked at $3.11M in Q1 2021.
445 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2022.

Based on AlphaCrest Capital Management's 13F filing for Q4 2022.